SlideShare a Scribd company logo
1 of 23
Lin Yang
Professor Peter Lipke’s Lab
Molecular, Cellular and Developmental Biology PhD program
Brooklyn College
The City University of New York
The spatial-temporal distribution of
amyloids in C. albicans biofilm
Outline
• Background
• Aims of this proposal
Rationale
Preliminary data
Experimental design
• Payoff
• Amyloids are cross beta-sheet
structures formed by the assembly
of a cluster of proteins or peptides.
• ways to detect amyloids:
• amyloid binding dyes: Thioflavin T,
Thioflavin S, Congo Red.
• electron microscopy
• software algorithms: TANGO,
ZipperDB
• aggregation assay
Douglas M. Fowler et.al science direct (2007)
• Yeast cell adhesion molecules
such as Als1p, Als5p of C.
abicans and Flo1p, Muc1p of
S. cerevisiae have functional
amyloid forming sequences.
Ramsook CB et.al Eukaryotic Cell. 2010
Melissa Garcia et.al PLoS ONE (2011)
A biofilm is composed of cell aggregates, which
are frequently embedded with extracellular
matrix.
Jonathan S. Finkel & Aaron P. Mitchell Nature
Reviews Microbiology (2011)
biofilm matrix
• Matrix components:
• Mannoproteins
• Carbohydrates
• Lipids
• eDNAs
Early, intermediate, mature phase of biofilm
Yeater et.al Microbiology (2007)
Melissa Garcia et.al PLoS ONE (2011)
Aim1: Anti-amyloids disrupt biofilm at early, intermediate
and mature phase.
Rationale
An Als anti-amyloid forming peptide (Als5pV326N
) and high concentration of
ThT inhibited biofilm formation at early phase.
D-amino acids causes the release of TasA amyloid fibers, which results
in the disassembly of biofilm in Bacillus subtilis.
Figure 3. D-tyrosine causes the release of TasA fibers
Figure 2. D-amino acids break
down pellicles.
Ilana Kolodkin-Gal et.al Sciece (2010)
An Als anti-amyloid forming peptide (Als5pV326N
) inhibits the density of
biofilm under fluid condition.
Cho Chan et.al Eukaryotic
Cell (2014 )
Aim1: anti-amyloids disrupt biofilm at early,
intermediate and mature phase.
• Preliminary data
ThT inhibited biofilm formation at early phase
Day185 4.5uM ThT 450uM ThT
A
B C
Crystal Violet XTT assay
ThT inhibited biofilm at intermediate and
mature phase
Rifamycin SV and Als5pV326N
peptide released more yeast
form cells from mature biofilm
Anti-amyloid Phase of biofilm affected Findings
Thioflavin T Early, Intermediate, Mature ThT caused the decrease of
biomass, metabolic rate of
biofilm at all phases. (XTT, Crystal
Violet data)
Als5 V326N
peptide Mature Als5 V326N
peptide caused yeast
form cells release from mature
biofilm. (CFU calculation,
microscopy)
Rifamycin SV Mature Rifamycin SV caused sparse
biofilm architecture and more
yeast form cells release at
mature phase.
Rifamycin SV and Als5pV326N
peptide did not affect early and intermediate
phase of biofilm based on XTT and Cyrstal violet assays.
Aim1: anti-amyloids disrupt biofilm at early, intermediate and
mature phase.
3. Experiments to do
• Test anti-amyloid property of rifamycin SV in C. albicans
biofilm forming system: Dot blot using matrix sample
extracted.
• Time course experiments to determine at which phase
other amyloid binding dyes (ThS, Congo Red) affect
biofilm (XTT, Crystal Violet, Microscopy)
• CFU calculation of cells released from mature biofilm
upon treatment.
• Confocal microscopy: determine the architecture of
biofilm upon treatment.
Aim 2: amyloids are in in vivo biofilm and are in the matrix of in
vitro C. albicans biofilm.
• 1. Rationale:
Diego Romero et.al PNAS (2010)
2. Preliminary data
Aim 2: amyloids are in the biofilm matrix of C. albicans grown in
vitro and in vivo.
3. Experiments to doTable 1. A list of experiments to be applied in Aim 2 and expected results
Assay Method Expected Result Controls
Extraction of SC 5314
biofilm matrix
Sonication,
centrifugation, dialysis,
lyophilization,
microscopy
Pi/Syto-9 Staining
Less than 5% of the
matrix is yeast cells
Intact cells
Detecting Als family
proteins in matrix
Dot blot, Als5p-biotin,
Avidin-HRP
Als family proteins are
in matrix sample
Als5 peptides,
Als5pV326N peptides
Staining proteins in the
matrix with ThT
fluorometer The fluorescence of ThT
increases after proteins
in the matrix is added.
ThT alone,
Als5 peptides,
Als5pV326N peptides
Discovery of amyloid
forming proteins in
matrix.
88% formic acid dissolves
matrix proteins, mass
spectrometry,
TANGO/ZipperDB
algorithm
There are more proteins
that are found in ms
when the proteins are
treated with formic acid
than trypsin.
TANGO/ZipperDB
positive proteins are
found in formic acid
treated matrix.
Matrix sample
dissolved in trypsin.
In vivo biofilm staining ThT staining, confocal
microscopy
Biofilm grown on the
catheter is ThT positive
Empty catheter, in vivo
B. subtilis biofilm and
tasA mutant biofilm
stained with ThT
Aim3: potential amyloid forming proteins are more
highly expressed in biofilm than planktonic cell state.
• 1. Rationale
Chandra et.al Journal of Bacteriology 2001
Aim3: potential amyloid forming
proteins are more highly expressed
in biofilm than planktonic cell state.
3. Experiments to do
Candidate genes->proteins
•N-terminal signal peptide
•GPI ancher
•TANGO/ZipperDB
Proteins that meet all the requirements
above are potential amyloid forming
proteins
Compare with the list to see whether
the potential amyloid forming proteins
are more highly expressed in biofilm.
Yeater et.al Microbiology (2007)
Payoff
• Aim 1 will determine when anti-amyloids affect biofilm in C.
albicans. (temporal)
• Aim2 will confirm or deny whether amyloids are in C. albicans
biofilm matrix. (spatial)
• Aim3 will determine whether amyloid forming proteins are
biofilm spefic and when these proteins are differently
expressed. (temporal)

More Related Content

What's hot

ChemE 395 final project
ChemE 395 final projectChemE 395 final project
ChemE 395 final project
ZI YANG
 
Working with Chromosomes
Working with ChromosomesWorking with Chromosomes
Working with Chromosomes
Ioanna Leontiou
 
Ret protooncogene
Ret protooncogeneRet protooncogene
Ret protooncogene
Anax Fotopoulos
 

What's hot (17)

Concept 12.3
Concept 12.3Concept 12.3
Concept 12.3
 
Proteomics and its applications in phytopathology
Proteomics and its applications in phytopathologyProteomics and its applications in phytopathology
Proteomics and its applications in phytopathology
 
Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1
 
Omics in crop improvement
Omics in crop improvementOmics in crop improvement
Omics in crop improvement
 
Genomics and its application in crop improvement
Genomics and its application in crop improvementGenomics and its application in crop improvement
Genomics and its application in crop improvement
 
ChemE 395 final project
ChemE 395 final projectChemE 395 final project
ChemE 395 final project
 
Techniques in proteomics
Techniques in proteomicsTechniques in proteomics
Techniques in proteomics
 
oncogene as a transcription activator
oncogene as a transcription activatoroncogene as a transcription activator
oncogene as a transcription activator
 
Gene regulatory networks
Gene regulatory networksGene regulatory networks
Gene regulatory networks
 
Genes, Genomics and Proteomics
Genes, Genomics and Proteomics Genes, Genomics and Proteomics
Genes, Genomics and Proteomics
 
Cell division cycle in yeast
Cell division cycle in yeast Cell division cycle in yeast
Cell division cycle in yeast
 
Working with Chromosomes
Working with ChromosomesWorking with Chromosomes
Working with Chromosomes
 
In Vitro Alternatives in Toxicology
In Vitro Alternatives in ToxicologyIn Vitro Alternatives in Toxicology
In Vitro Alternatives in Toxicology
 
Proteomics
ProteomicsProteomics
Proteomics
 
Isolation of promoters and other regularly elements
Isolation of promoters and other regularly elementsIsolation of promoters and other regularly elements
Isolation of promoters and other regularly elements
 
Ret protooncogene
Ret protooncogeneRet protooncogene
Ret protooncogene
 
Control of gene expression in plants
Control of gene expression in plantsControl of gene expression in plants
Control of gene expression in plants
 

Similar to 2nd level presentation (1) (1)

west palm beach poster (1)
west palm beach poster (1)west palm beach poster (1)
west palm beach poster (1)
Lynn Yang
 
Ezhil Final. Ppt
Ezhil Final. PptEzhil Final. Ppt
Ezhil Final. Ppt
guest094207
 
Modulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionModulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibition
David Andrews
 
Bioassay development part 4
Bioassay development   part 4Bioassay development   part 4
Bioassay development part 4
Colin Rickman
 

Similar to 2nd level presentation (1) (1) (20)

west palm beach poster (1)
west palm beach poster (1)west palm beach poster (1)
west palm beach poster (1)
 
Ezhil Final. Ppt
Ezhil Final. PptEzhil Final. Ppt
Ezhil Final. Ppt
 
Apoptosis assays detection and methods
Apoptosis assays   detection and methodsApoptosis assays   detection and methods
Apoptosis assays detection and methods
 
Modulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionModulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibition
 
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
L-arginine modulates T cell metabolism and enhances survival and anti-tumor A...
 
USRTP Poster
USRTP PosterUSRTP Poster
USRTP Poster
 
SWON Alliance Cross Council AMR Collaborative
SWON Alliance Cross Council AMR CollaborativeSWON Alliance Cross Council AMR Collaborative
SWON Alliance Cross Council AMR Collaborative
 
Ponatinib tox poster SOT_2016
Ponatinib tox poster SOT_2016Ponatinib tox poster SOT_2016
Ponatinib tox poster SOT_2016
 
Rapid microbiological methods
Rapid microbiological methodsRapid microbiological methods
Rapid microbiological methods
 
Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to Combinations
 
Bioassay development part 4
Bioassay development   part 4Bioassay development   part 4
Bioassay development part 4
 
Seminario biologia molecular final
Seminario  biologia molecular final Seminario  biologia molecular final
Seminario biologia molecular final
 
Protein Chromatography
Protein ChromatographyProtein Chromatography
Protein Chromatography
 
JBEI highlights September 2019
JBEI highlights September 2019JBEI highlights September 2019
JBEI highlights September 2019
 
Bacterial spore
Bacterial sporeBacterial spore
Bacterial spore
 
Western blotting
Western blottingWestern blotting
Western blotting
 
high throughput tilling for functional genomics
high throughput tilling for functional genomicshigh throughput tilling for functional genomics
high throughput tilling for functional genomics
 
Cupid Peptides presentation wjr
Cupid Peptides presentation wjrCupid Peptides presentation wjr
Cupid Peptides presentation wjr
 
Diagnosis of mycoplasmosis in goats
Diagnosis of mycoplasmosis in goatsDiagnosis of mycoplasmosis in goats
Diagnosis of mycoplasmosis in goats
 
ICC Final Paper
ICC Final PaperICC Final Paper
ICC Final Paper
 

2nd level presentation (1) (1)

  • 1. Lin Yang Professor Peter Lipke’s Lab Molecular, Cellular and Developmental Biology PhD program Brooklyn College The City University of New York The spatial-temporal distribution of amyloids in C. albicans biofilm
  • 2. Outline • Background • Aims of this proposal Rationale Preliminary data Experimental design • Payoff
  • 3. • Amyloids are cross beta-sheet structures formed by the assembly of a cluster of proteins or peptides. • ways to detect amyloids: • amyloid binding dyes: Thioflavin T, Thioflavin S, Congo Red. • electron microscopy • software algorithms: TANGO, ZipperDB • aggregation assay Douglas M. Fowler et.al science direct (2007)
  • 4. • Yeast cell adhesion molecules such as Als1p, Als5p of C. abicans and Flo1p, Muc1p of S. cerevisiae have functional amyloid forming sequences. Ramsook CB et.al Eukaryotic Cell. 2010 Melissa Garcia et.al PLoS ONE (2011)
  • 5. A biofilm is composed of cell aggregates, which are frequently embedded with extracellular matrix. Jonathan S. Finkel & Aaron P. Mitchell Nature Reviews Microbiology (2011)
  • 6. biofilm matrix • Matrix components: • Mannoproteins • Carbohydrates • Lipids • eDNAs
  • 7. Early, intermediate, mature phase of biofilm Yeater et.al Microbiology (2007)
  • 8. Melissa Garcia et.al PLoS ONE (2011) Aim1: Anti-amyloids disrupt biofilm at early, intermediate and mature phase. Rationale An Als anti-amyloid forming peptide (Als5pV326N ) and high concentration of ThT inhibited biofilm formation at early phase.
  • 9. D-amino acids causes the release of TasA amyloid fibers, which results in the disassembly of biofilm in Bacillus subtilis. Figure 3. D-tyrosine causes the release of TasA fibers Figure 2. D-amino acids break down pellicles. Ilana Kolodkin-Gal et.al Sciece (2010)
  • 10. An Als anti-amyloid forming peptide (Als5pV326N ) inhibits the density of biofilm under fluid condition. Cho Chan et.al Eukaryotic Cell (2014 )
  • 11. Aim1: anti-amyloids disrupt biofilm at early, intermediate and mature phase. • Preliminary data
  • 12. ThT inhibited biofilm formation at early phase Day185 4.5uM ThT 450uM ThT A B C Crystal Violet XTT assay
  • 13. ThT inhibited biofilm at intermediate and mature phase
  • 14. Rifamycin SV and Als5pV326N peptide released more yeast form cells from mature biofilm
  • 15.
  • 16. Anti-amyloid Phase of biofilm affected Findings Thioflavin T Early, Intermediate, Mature ThT caused the decrease of biomass, metabolic rate of biofilm at all phases. (XTT, Crystal Violet data) Als5 V326N peptide Mature Als5 V326N peptide caused yeast form cells release from mature biofilm. (CFU calculation, microscopy) Rifamycin SV Mature Rifamycin SV caused sparse biofilm architecture and more yeast form cells release at mature phase. Rifamycin SV and Als5pV326N peptide did not affect early and intermediate phase of biofilm based on XTT and Cyrstal violet assays.
  • 17. Aim1: anti-amyloids disrupt biofilm at early, intermediate and mature phase. 3. Experiments to do • Test anti-amyloid property of rifamycin SV in C. albicans biofilm forming system: Dot blot using matrix sample extracted. • Time course experiments to determine at which phase other amyloid binding dyes (ThS, Congo Red) affect biofilm (XTT, Crystal Violet, Microscopy) • CFU calculation of cells released from mature biofilm upon treatment. • Confocal microscopy: determine the architecture of biofilm upon treatment.
  • 18. Aim 2: amyloids are in in vivo biofilm and are in the matrix of in vitro C. albicans biofilm. • 1. Rationale: Diego Romero et.al PNAS (2010)
  • 20. Aim 2: amyloids are in the biofilm matrix of C. albicans grown in vitro and in vivo. 3. Experiments to doTable 1. A list of experiments to be applied in Aim 2 and expected results Assay Method Expected Result Controls Extraction of SC 5314 biofilm matrix Sonication, centrifugation, dialysis, lyophilization, microscopy Pi/Syto-9 Staining Less than 5% of the matrix is yeast cells Intact cells Detecting Als family proteins in matrix Dot blot, Als5p-biotin, Avidin-HRP Als family proteins are in matrix sample Als5 peptides, Als5pV326N peptides Staining proteins in the matrix with ThT fluorometer The fluorescence of ThT increases after proteins in the matrix is added. ThT alone, Als5 peptides, Als5pV326N peptides Discovery of amyloid forming proteins in matrix. 88% formic acid dissolves matrix proteins, mass spectrometry, TANGO/ZipperDB algorithm There are more proteins that are found in ms when the proteins are treated with formic acid than trypsin. TANGO/ZipperDB positive proteins are found in formic acid treated matrix. Matrix sample dissolved in trypsin. In vivo biofilm staining ThT staining, confocal microscopy Biofilm grown on the catheter is ThT positive Empty catheter, in vivo B. subtilis biofilm and tasA mutant biofilm stained with ThT
  • 21. Aim3: potential amyloid forming proteins are more highly expressed in biofilm than planktonic cell state. • 1. Rationale Chandra et.al Journal of Bacteriology 2001
  • 22. Aim3: potential amyloid forming proteins are more highly expressed in biofilm than planktonic cell state. 3. Experiments to do Candidate genes->proteins •N-terminal signal peptide •GPI ancher •TANGO/ZipperDB Proteins that meet all the requirements above are potential amyloid forming proteins Compare with the list to see whether the potential amyloid forming proteins are more highly expressed in biofilm. Yeater et.al Microbiology (2007)
  • 23. Payoff • Aim 1 will determine when anti-amyloids affect biofilm in C. albicans. (temporal) • Aim2 will confirm or deny whether amyloids are in C. albicans biofilm matrix. (spatial) • Aim3 will determine whether amyloid forming proteins are biofilm spefic and when these proteins are differently expressed. (temporal)

Editor's Notes

  1. a. aB fiber structure from NMR cross b sheet structure. b. transmission electron micrograph of islet amyloid polypeptide. c. x ray fiber diffraction pattern of ab 1-42 associated with alzheimer's disease
  2. In our lab, our focus is amyloid forming proteins. the monomers are covalently anchored on the cell wall of yeast cells. After amyloid regions are exposed, the monomers are clustered through the interaction of amyloid forming sequences.
  3. | Scanning electron micrograph (SEM) of an in vitro Candida albicans biofilm. The biofilm sample was sliced to show three layers in a cross-sectional view. The basal layer primarily includes yeast cells, as is evident in the lower enlarged inset. The central layer is mainly hyphae. The upper layer has yeast cells budding from the hyphae. The upper enlarged inset shows the extracellular matrix material, which seems fibrous in this preparation. b | SEM of an in vivo C. albicans biofilm from the rat catheter model11. Yeast cells, hyphae and some pseudohyphal cells are evident, along with extracellular matrix material. Images courtesy of J. Suhan (Carnegie Mellon University, Pittsburgh, Pennsylvania, USA), and J. Nett and D. Andes (University of Wisconsin–Madison, USA).
  4. Matrix: immobilize biofilm cells and keep them in close proximity,help cell-cell interaction. proteins: structural protein stablize matrix, interation with polysaccharides. Enzymes. Food resources. DNAs: structural(treat with nucleolytic enzymes, lose of flocculation). adhesion. antimicrobial activity. Lipids: adherence to surface. "surfactants"
  5. Fig. 3.Summary of the cellular processes that are associated with genes upregulated at the different time points duringC. albicansbiofilm development. The time-course of biofilm development is shown, highlighting the time points (6, 12 and 48 h) studied by microarray analysis. Descriptions of cellular processes are summarized from the detailed data presented in Supplementary Table S1. Categories of genes upregulated at 6 vs 12 h are summarized under the 6 h heading. Data from both the 12 vs 6 h and 12 vs 48 h comparisons are placed under the 12 h heading. Few genes are upregulated at 48 h compared to 12 h, suggesting that initiation of new metabolic activity is relatively low in the mature biofilm. The individual genes upregulated at 48 vs 12 h are listed
  6. In her C. albicans model, biofilm is incubated at 30 oC with YPD medium, under which condition hyphae are not formed. However, this in vitro model is not appropriate for the study of systemic candidiasis, because this disease occurs at 37oC and hyphal formation is necessary for systemic infections (31, 31). Therefore, I will mimic the natural state of biofilm and induce hyphae formation in this project. I will grow C. albicans biofilm at 37 oC with RPMI-MOPs, which specifically induce hyphae. This system can mimic the physiological temperature in human body and is accepted by National Committee for Clinical Laboratory Standards of antifungal susceptibility study
  7. yqxM6 is a A:T base pair mutation at 569 mutant cells. these cells are resistant to D amino acids treatment. wild type yqxM gene is requied for the association of tas A with cells
  8. 2 Biofilm growth for S. cerevisiae strains at two shear stresses. Biofilms of S. cerevisiae expressing Als5p or Als5pV326N or harboring an empty vector. Adherent cells were grown under laminar flow for 48
  9. Propidium iodide
  10. gold labeled anti-tasA antibodies. biofilm formation is impaired by tasA and eps mutants.
  11. OC (recognizing the cross-stacked β-sheet structure of fibrillar oligomers, protofibrils, and fibrils [51] Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers